FMW Media's
New to The
Street / Newsmax T.V. announces on Sunday,
May 15, 2022, the broadcasting line-up of its national syndicated
1-hour T.V. show, airing 10-11 AM ET.
New to The Street's 344th T.V. episode
line-up, features eight (8) interviews of the following Companies
and their businesses representatives:
1). Tonix Pharmaceuticals,
Inc.'s (NASDAQ: TNXP) interview with Dr. Seth Lederman, MD,
CEO. 2). Sekur Private Data, Ltd.'s (fka
-GlobeX Data, Ltd.) (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0)
interview with Mr. Alain Ghiai, CEO. 3). Rego Payments
Architectures, Inc.'s. (OTCQB: RPMT) interview with Mr. Stuart
Harvey, Chairman of the Board of Advisors. 4). Crypto Gaming
- Splinterlands.com's (CRYPTO: SPS) ($SPS) interview
with Mr. Jesse Reich ("aggroed"), CEO, Steem Monsters, LLC.
5). Cryptocurrency – Empire Capital Token's (CRYPTO:
ECC)($ECC) interview with Mr. Lachlan Harnell, Chief
Operations Officer (COO). 6). Walnut's interview with Mr.
Yoav Vilner, CEO. 7). PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) interview with Mr. John Lai, CEO /
President. 8). Sekur Private Data Ltd.'s (Sekur®)
(fka -GlobeX Data, Ltd.) (OTCQX: SWISF) (CSE: SKUR) (FRA:
GDT0) the "Weekly Hack - SPECIAL
SEGMENT," interview with internet privacy expert Mr.
Alain Ghiai, CEO.
New to The Street T.V. brings back the CEO
at Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP), Dr. Seth
Lederman, MD. During the interview with T.V. Anchor Jane King, Dr.
Lederman explains how the TNXP's fibromyalgia drug, TNX-102
SL, could help alleviate those with Long COVID symptoms. Chronic
widespread pain, non-restorative sleep, fatigue, and impaired
cognition (brain fog) are symptoms found within 1/3 of those who
have contracted long-covid, similar to those with fibromyalgia. The
U.S. Food and Drug Administration (FDA) recently cleared TNXP
for an Investigational New Drug (IND) application to support a
Phase 2 clinical trial using TNX-102 SL as a potential treatment
for patients with Long COVID. There is an expectation that millions
inflicted with Long COVID across the U.S. and worldwide will cause
a significant burden on health care systems. In the U.K., 25%
apparently cannot work. Dr. Lederman talks about TNX-102 SL's
mid-Phase 3 development for managing fibromyalgia. Using a
dissolvable sublingual tablet to improve sleep is not a typical
sleeping pill with many side effects. A good sleep cycle is
essential in helping crack the code in patients with fibromyalgia.
Dr. Lederman sees an opportunity to help many with the TNX- 102
SL.
Appearing in-studio at the Nasdaq
Marketplace, Mr. Alain Ghiai, CEO, Sekur Private Data,
Ltd. (fka -GlobeX Data, Ltd.) (OTCQX: SWISF)
(CSE: SKUR) (FRA: GDT0) talks with T.V. Anchor Jane King about the
Company's newest encrypted product, "Chat-by-Invite." This new text
message tool, available in the USA, Canada, Australia, New Zealand,
Switzerland, and most of Latin America and Europe, gives
subscribers an utterly private chat. It works when the Sekur
subscriber sends a text message to a recipient, and a link
appears that opens into a private, secure platform hosted in
Switzerland. Essentially, the chat occurs on the Swiss servers
owned and controlled by Sekur Private Data, Ltd. Once the text
message session completes, the text disappears. Hackers won't know
about the transmission because of the highly encrypted military
technology operating behind the product. There is no direct texting
on open-source platforms, making them invulnerable to cybersecurity
breaches. The SekurMail / SekurMessenger, SekurVoice,
SekurProVideo Conference, and other products are available now or
soon. Sekur's "Chat-by-Invite" app is available on iOS and Android;
go to Sekur.com to download it. Subscribers get
cybersecurity protections not available with open-source programs
for reasonable pricing. As an added protection to subscribers,
Sekur Private Data, Ltd operates its internet platforms and
security businesses under the country of Switzerland's very tough
privacy laws.
A re-airing, live from the NASDAQ
Market, Mr. Stuart Harvey, Chairman of the Board of Advisors
at Rego Payment Architectures, Inc. (OTCQB: RPMT) ("REGO")
joins New to The Street, giving T.V. Anchor Jane King. During the
interview about the Company's fundamental ongoings, Stuart talks
about his many years of business in the payment industry, financial
technologies, digital wallets, and pre-paid cards. REGO takes
payment options to a new level, securing children's privacy when
purchasing online or in stores. Stuart passionately explains the
need for such solutions and a primary reason for him being with the
Company. As the only COPPA compliant digital wallet,
the Mazoola super digital wallet app is currently the
only digital banking solution that puts privacy first, never
collects data, and helps teach kids essential financial management
skills. The wallet offers parents the ability to set payment and
shopping limits and other restrictions. Stuart explains the
expanding governmental enforcement efforts in the U.S. and Europe
under the current Children's Online Privacy Protection Act
(COPPA) and General Data Protection Regulation
(GDPR). Mazoola is currently the only digital banking solution
that puts children's privacy first. The Mazoola app is available
for download on iOS and Google Android devices
- https://mazoola.co/. This interview segment initially aired
on May 01, 2022.
Mr. Jessie Reich ("aggroed"), Chief Executive
Officer, Steem Monsters, LLC, sits down for his New York Stock
Exchange (NYSE) in-studio interview with New to The Street
T.V. Anchor Jane King. Jessie explains and updates viewers about
the Company's gaming platform Splinterlands.com (CRYPTO:
SPS) ($SPS). Splinterlands' goal is to become a completely
decentralized game that allows players full ownership and control
over their gaming accounts. With censorship occurring on legacy
gaming platforms, players removed from these games lose their
assets, banked earnings, and rankings, which cost hundreds of
thousands of dollars. Splinterlands' ecosystem is fully functional
on a blockchain, fully decentralized, which protects users'
privacy, assets, and financial holdings from potential losses
caused by censorship. Jessie explains that Splinterlands is
switching over to decentralized validator nodes before the end of
2022. The validator node software is fully open-source, easily
allowing anyone to download, install, and run it with no extra
cost/fees. These nodes can surely provide added value to end-users.
Those in the ecosystem with time, money, or both enjoy the many
ways to "Play-to-Earn." "aggroed" wants Splinterlands to be the W3
gaming marketplace with various gaming platforms. The Company
continues to look for other avenues to expand the reach of its
ecosystem with the recent announcements with Warner
Music and future blockchain integrations with sporting
venues.
New to The Street T.V. air on this week's show is
Anchor Jane King's interview with Empire
Capital Token's (CRYPTO: ECC)($ECC) Chief Operations
Officer, Mr. Lachlan Harnell. $ECC is a multi-faceted, yield
generation crypto company offering Defi as a service (Defi 4.0).
Lachlan explains how the Company can assist in various blockchain
applications using its Defi solutions. Currently, the Company
provides blockchain developers farming, infrastructure, and other
Defi solutions. The main objective at $ECC is to get more people
into the crypto marketplace, making more users feel confident about
crypto transactions and investments. The $ECC ecosystem offers
end-users a platform with a decentralized focus and offers easy
access to crypto solutions for payments on goods/services. The
Company is developing its "Roundify" app, which offers a Defi
access platform on iOS and Android, expected to roll out later in
2022. Lachlan talks about $ECC tokenization and the 9% fees
generated on the buy-side and the 10% fees on the sell-side
transactions, and he breakdowns the use of proceeds on those fees
collected. The Company's treasury will buy back tokens, raising the
$ECC prices that allow an investor a Rate-of-Return (ROI) on their
holdings. Empire Capital Token removes the need for active
management by the user by creating opportunities to diversify
holdings in projects focused on maximizing staking/farming yields.
Users gain the advantage of broader exposure to the yield farming
sector while only needing to own one token, $ECC. The crypto world
is fast-moving with many advances and changes; Lachlan states, "the
industry moves at the pace of the fastest sprinter." $ECC offers
developers and end-user alike the opportunity to be involved in a
cutting-edge Defi entity. The Company currently operates its
ecosystem on the Binance exchange and Ethereum blockchain. To learn
more, go to the Company's
website, https://www.ecc.capital/.
Mr. Yoav Vilner, CEO at Walnut, talks with
New to The Street T.V.'s Anchor Jane King about the Company. Based
in Israel with office locations in the USA, Walnut provides its
customers with high-tech video demos, which can enhance the sale
and marketing of targeted goods and services. Never again will a
salesperson or marketing executive have embarrassment when a demo
fails to launch correctly during a presentation. Walnut's web-based
interface, a user-friendly platform, can assist in putting together
a cutting-edge demo that can showcase products and services.
Fortune 500 companies to small businesses use the Walnut solution
to create easy-to-understand demos. Yoav explains that Walnut's
growth continues to expand in such a short period. Silicon Valley,
Israeli, and London-based investment funds invested in Walnut, and
the proceeds went to all business operational aspects. As an
easy-to-use web-based platform, any business can create a virtual
demo uniquely suited to the prospective target clients' needs. The
sales/marketing team can easily change the demo quickly with less
expenses and get useable interface data. Walnut can empower your
business team, impress your target customers, and create a unique
sales experience with a smart demo developed on a web-based
platform. Walnut's vision is to improve B2B sales experiences by
reinventing the whole demo journey; learn more at the Company's
website, https://www.walnut.io/.
New to The Street T.V. re-airs Mr. John Lai, CEO /
President, PetVivo Holdings,
Inc. (NASDAQ: PETV) (NASDAQ: PETVW),
in-studio Nasdaq Marketplace interview with T.V. Anchor
Jane King. John provides viewers with his corporate updates. The
injectable patented Spryng with OsteoCushion
Technology treats osteoarthritis and joint afflictions while
providing rehabilitation treatments for horses and dogs and
continues to grow as a reliable treatment. Veterinarians see
continued successes, and dog and horse owners see excellent results
with less pain and more mobilities. Since Spryng mimics cartilage
and lasts about 1-year per injection, competitor products appear to
be no match in cost-benefit comparisons. PETV's corporate studies
continue between Spryng and competitors' products, giving
veterinarians empirical, comprehensive, and marketable data. John
talks about hiring seasoned personnel who became regional managers
so the Company can handle and expand its growth. John announces its
upcoming launch of petvivocares.org, a website dedicated to
donating the Spryng product to charitable non-profit animal rescues
and assistance organizations. "Word of Mouth" and conference
participations seem to be the best form of marketing PETV's Spryng
with OsteoCushion Technology. Soon, PetVivo is rolling out its
feline product for cats with osteoarthritis. This interview segment
initially aired on April 10, 2022.
New to The Street re-airs last
week's "WEEKLY HACK - SPECIAL
SEGMENT" about Sekur
Private Data Ltd. (fka
-GlobeX Data, Ltd.) (OTCQB: SWISF) (CSE:
SKUR) (FRA: GDT0), with the internationally acclaimed internet
privacy expert, Mr. Alain Ghiai, CEO. Once again, Alain talks with
Anchor Ana Berry about the problems employers have with employees
working from home. The biggest issue confronting employers' I.T.
departments with their employees working from home is logging onto
their system from unsecured home routers and using open platforms,
like WhatsApp, to communicate private and confidential information.
Since the pandemic forced workers into home office settings,
hackers prey on these poorly secured home platforms, enabling
hackers access to large corporations' main servers. Alain says that
most home systems use very rudimentary passwords, like the word
"Password" or number "1,2,3,4." The best way to reduce a hack
threat is to subscribe to the SekurSuite products for
individuals and businesses. The SekurSend and
SekurReply use a "Chat-by-Invite" encryption platform that
protects both sender and receiver. Alain invites anyone to learn
more about the Sekur features by watching the Company website
videos. Sekur doesn't use open public files services or open-source
codes, owns its servers, no 3rd party API platforms, and offers
multiple data center redundancies while operating its businesses
under Switzerland's very tough privacy laws. Alain is back again
soon with another "Weekly Hack" report. This interview
segment initially aired on May 08, 2022. What is your
privacy worth?
About Tonix Pharmaceuticals Holding Corp.
(NASDAQ: TNXP):
Tonix Pharmaceuticals Holding Corp. (NASDAQ:
TNXP) is a clinical-stage biopharmaceutical company focused on
discovering, licensing, acquiring, and developing small molecules
and biologics to treat and prevent human disease and alleviate
suffering. Tonix's portfolio comprises immunology, rare disease,
infectious disease, and central nervous system (CNS) product
candidates. Tonix's immunology portfolio includes biologics to
address organ transplant rejection, autoimmunity, and cancer.
TNX-15001 is a humanized monoclonal antibody targeting CD40-ligand
in development to prevent the prevention of allograft and xenograft
rejection and for the treatment of autoimmune diseases. A Phase 1
study of TNX-1500 is expected to be initiated in the second half of
2022. Tonix's rare disease portfolio includes TNX-29002 for the
treatment of Prader-Willi syndrome. The FDA has granted TNX-2900
Orphan-Drug Designation. Tonix's infectious disease pipeline
consists of a vaccine in development to prevent smallpox and
monkeypox called TNX-8013, next-generation vaccines to prevent
COVID-19, and an antiviral to treat COVID-19. Tonix's lead vaccine
candidates for COVID-19 are TNX-1840 and TNX-18504, live virus
vaccines based on Tonix's recombinant pox vaccine (RPV) platform.
TNX-35005 (sangivamycin, i.v. solution) is a small
molecule antiviral drug to treat acute COVID-19 and is in the
pre-IND stage of development. TNX-102 SL, (cyclobenzaprine HCl
sublingual tablets) is a small molecule drug being developed to
treat Long COVID, a chronic post-acute COVID-19 condition. Tonix
expects to initiate a Phase 2 study in Long COVID in the second
quarter of 2022. The Company's CNS portfolio includes small
molecules and biologics to treat pain, neurologic, psychiatric, and
addiction conditions. Tonix's lead CNS candidate, TNX-102 SL, is in
mid-Phase 3 development for the management of fibromyalgia, with a
new Phase 3 study launched in the second quarter of 2022. Finally,
TNX-13006 is a biologic designed to treat cocaine intoxication that
is expected to start a Phase 2 trial in the second quarter of 2022
- https://www.tonixpharma.com. (1TNX-1500 is an
investigational new biologic at the pre-IND stage of development
and has not been approved for any indication.2TNX-2900 is an
investigational new drug at the pre-IND stage of development and
has not been approved for any indication.3TNX-801 is a live
horsepox virus vaccine for percutaneous administration in
development to protect against smallpox and monkeypox. TNX-801 is
an investigational new biologic and has not been approved for any
indication.4TNX-1840 and TNX-1850 are live horsepox virus vaccines
for percutaneous administration, in development to protect against
COVID-19. TNX-1840 and TNX-1850 are designed to express the
SARS-CoV-2 spike protein from the omicron and BA.2 variants,
respectively. TNX-1840 and TNX-1850 are investigational new
biologics at the pre-IND stage of development and have not been
approved for any indication. 5TNX-3500 is an investigational new
drug at the pre-IND stage of development and has not been approved
for any indication.6TNX-1300 is an investigational new biologic and
has not been approved for any indication.)
About Sekur Private Data
Ltd. (fka- GlobeX Data, Ltd.) (OTCQX:
SWISF) (CSE: SKUR) (FRA: GDT0):
Sekur Private Data, Ltd. (fka- GlobeX Data,
Ltd.) (OTCQX: SWISF) (CSE: SKUR) (FRA:
GDT0) is a Cybersecurity and Internet privacy
provider of Swiss hosted solutions for secure communications and
secure data management. The Company distributes encrypted emails,
secure messengers, secure communication tools, secure cloud-based
storage, disaster recovery, and document management products. The
Company sells and serves consumers, businesses, and governments
worldwide through approved wholesalers, distributors, and
telecommunications companies. Contact Sekur Private Data, Ltd. at
corporate@globexdatagroup.com or
visit https://www.sekurprivatedata.com and https://www.sekur.com.
About REGO Payment Architectures, Inc.
(OTCQB: RPMT):
REGO Payment Architectures, Inc. (OTCQB:
RPMT) ("REGO") is a digital solution that enables children to stay
safe in today's tech-first environment. The REGO Digital Wallet
platform, Mazoola, allows parents and guardians to enable
online shopping or digital spending at approved retailers, control
what funds are available for which purchases, and reward children
or pay allowance via the app. REGO is an innovative financial
platform uniquely positioned due to its Children's Online Privacy
Protection Act (COPPA) and General Data Protection Regulation
(GDPR) compliance- www.regopayments.com.
About
Splinterland.com (CRYPTO: SPS)
($SPS):
Splinterlands.com (CRYPTO: SPS)
($SPS) is the first strategy card game to provide a seamlessly
integrated marketplace that gives the player FULL CONTROL of their
cards. These cards are non-fungible tokens (NFT's) with real
monetary value. Players can buy, sell, or trade these digital
assets just like physical trading cards. Splinterlands runs on the
Hive blockchain, recording all actions in the game on the
blockchain. That means anyone can join the game by creating a Hive
blockchain address, making the game permissionless. It also
provides Splinterlands with a transparent record of all actions in
the game, including battle results, which ensures fairness and
transparency. Earn anywhere at any time. Splinterlands is available
on both desktop and mobile devices
- https://splinterlands.com/.
About Empire Capital
Token (CRYPTO: ECC)
($ECC):
Empire Capital Token (CRYPTO: ECC)
($ECC) is a Defi 3.0 high yield farming & staking smart
contract allowing holders to earn high rewards from a cross-chain
decentralized exchange, EmpireDEX. The Company is a multi-faced
yield generating organization providing Defi-as-a-Service, which is
the synthesis of Farming-as-a-Service, Infrastructure-as-a-Service,
and a suite of development services and tools. Empire Capital is
advancing the boundaries of decentralized finance itself by
encouraging crypto accessibility and normalization through its
groundbreaking app, Roundify. Empire Capital aims to be
the access point for new users to enter the decentralized world
- https://www.ecc.capital/ and https://rua.ecc.capital/.
About Walnut:
Walnut is the world's first failure-free,
codeless, and 100% customizable platform that empowers every sales
rep to own their successful sales demo experience. Businesses can
Create specific sales and product demos easily. Walnut offers
personalized, consistent, and successful demos every single time.
Collect data on the usage of a demo and optimize the performance to
provide prospects with the highest possible value
- https://www.walnut.io/.
About PetVivo Holdings, Inc. (NASDAQ:
PETV) (NASDAQ: PETVW):
PetVivo Holdings, Inc. (NASDAQ: PETV)
(NASDAQ: PETVW) is an emerging biomedical device company currently
focused on the manufacturing, commercialization, and licensing of
innovative medical devices and therapeutics for companion animals.
The Company's strategy is to leverage human therapies to treat
companion animals in a capital and time-efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices that enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products to treat animals and
people. A portfolio of nineteen patents protects the Company's
biomaterials, products, production processes, and use methods. The
Company's lead product Spryng with OsteoCushion Technology, a
veterinarian-administered, intraarticular injection to treat
lameness and other joint-related affliction, including
osteoarthritis, in dogs and horses, is currently available for
commercial sale to veterinarians
- https://petvivo.com/ & https://www.sprynghealth.com/.
About FMW Media:
FMW Media operates one of the longest-running
U.S. and International sponsored and Syndicated Nielsen Rated
programming T.V. brands, "New to The Street" and its blockchain
show "Exploring The Block." Since 2009, these brands have run
biographical interview segment shows across major U.S. Television
networks. The T.V. platforms reach over 540 million homes in the
U.S. and international markets. FMW's New to The Street / Newsmax
T.V. broadcasting platform airs its syndication on Sundays at 10
-11 AM ET. FMW is also one of the nation's largest buyers of linear
television long and short-form
- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.
Forward-Looking Statements
Disclaimer:
This press release contains forward-looking
statements within Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934. In
some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology.
However, not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at which such performance or results are
achieved. This press release should be considered in all filings of
the Companies contained in the Edgar Archives of the Securities and
Exchange Commission at www.sec.gov.
CONTACT:
FMW Media Contact: Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
"New to The Street" Business Development office.
1-516-696-5900 Support@NewtoTheStreet.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/56bba8a9-4047-454f-afdc-b4d619c89c1a
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Aug 2024 to Sep 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Sep 2023 to Sep 2024